MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
$37,890K
EPS
$0.6
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Impairment of intangible assets
--649* 0 58,710
Revenue, net
36,220 34,125 26,063 25,881
Cost of product revenue
1,897 1,520 1,238 12,379
Intangible asset amortization
316 966* 315 1,616
Gain on sale of future royalties, intellectual property, and other assets, net
43,314 ---
Research and development
4,392 2,620 3,432 3,433
Selling, general and administrative
20,783 20,354 16,935 20,782
Total operating expenses
25,175 22,974 20,367 24,215
Income (gain) from operations
52,146 9,315 4,143 -71,039
Loss on extinguishment of debt
-2,756 ---
Loss on sale of prv
--6,195* 0 148,325
Loss on derivative liability
-7,216 ---
Interest expense
1,711 1,887* 2,051 2,009
Fair value adjustment related to warrant and cvr liability
-968 -11,557* 5,506 747
Fair value adjustment related to investments
216 34* -124 2
Interest and other income, net
3,589 -90* 2,313 2,378
Total other (expense) income
-7,342 3,351 -5,120 147,945
Income (loss) before income taxes
44,804 12,666 -977 76,906
Income tax expense
6,914 501 -433 2,199
Net income (loss)
37,890 12,165 -544 74,707
Basic EPS
0.62 0.216 -0.01 1.24
Diluted EPS
0.6 0.204 -0.01 1.21
Basic Average Shares
58,405,955 56,417,179 55,951,572 54,780,938
Diluted Average Shares
60,230,490 59,511,670 55,951,572 56,324,903
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Gain on sale of futureroyalties, intellectual...$43,314K Revenue, net$36,220K (77.54%↑ Y/Y)Income (gain) fromoperations$52,146K (1072.51%↑ Y/Y)Total operatingexpenses$25,175K (10.40%↑ Y/Y)Cost of productrevenue$1,897K (41.04%↑ Y/Y)Intangible assetamortization$316K (-80.43%↓ Y/Y)Income (loss) beforeincome taxes$44,804K (2437.19%↑ Y/Y)Total other (expense)income-$7,342K (-313.12%↓ Y/Y)Interest and otherincome, net$3,589K Selling, general andadministrative$20,783K (6.33%↑ Y/Y)Research and development$4,392K (34.81%↑ Y/Y)Fair valueadjustment related to...-$968K Net income (loss)$37,890K (1322.65%↑ Y/Y)Income tax expense$6,914K (484.94%↑ Y/Y)Loss on derivativeliability-$7,216K Loss onextinguishment of debt-$2,756K Interest expense$1,711K Fair valueadjustment related to...$216K

ZEVRA THERAPEUTICS, INC. (ZVRA)

ZEVRA THERAPEUTICS, INC. (ZVRA)